Financials SoftMedx Healthcare Limited

Equities

648

HK0000375797

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. 03:08:44 2019-02-21 am EST 5-day change 1st Jan Change
0.38 HKD -.--% Intraday chart for SoftMedx Healthcare Limited -.--% -.--%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 123.9 123.9 123.9 123.9 123.9 123.9
Enterprise Value (EV) 1 292.3 348.6 373 386.7 396.1 406.3
P/E ratio -1.87 x -1.61 x -2.44 x -4.72 x -6.44 x 9.9 x
Yield - - - - - -
Capitalization / Revenue 2.13 x 3.09 x 12.9 x 72.9 x 3.67 x 2.41 x
EV / Revenue 5.02 x 8.68 x 38.8 x 228 x 11.7 x 7.91 x
EV / EBITDA -5.84 x -8.26 x -11.8 x -18.6 x -44.2 x 64.9 x
EV / FCF 69.5 x -26.1 x -37.3 x -16.8 x -74 x -21.9 x
FCF Yield 1.44% -3.83% -2.68% -5.96% -1.35% -4.56%
Price to Book -1.68 x -0.52 x -0.43 x -0.39 x -0.37 x -0.38 x
Nbr of stocks (in thousands) 326,037 326,037 326,037 326,037 326,037 326,037
Reference price 2 0.3800 0.3800 0.3800 0.3800 0.3800 0.3800
Announcement Date 11/5/23 11/5/23 11/5/23 11/5/23 11/5/23 4/24/24
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 58.23 40.16 9.617 1.699 33.76 51.34
EBITDA 1 -50.02 -42.22 -31.73 -20.83 -8.951 6.263
EBIT 1 -52.64 -43.65 -32.18 -21.05 -9.284 6.038
Operating Margin -90.4% -108.7% -334.65% -1,238.79% -27.5% 11.76%
Earnings before Tax (EBT) 1 -64.77 -79.22 -52.47 -24.72 -16.63 14.37
Net income 1 -66.08 -76.98 -50.85 -26.28 -19.22 12.51
Net margin -113.48% -191.71% -528.71% -1,546.5% -56.94% 24.37%
EPS 2 -0.2027 -0.2361 -0.1560 -0.0806 -0.0590 0.0384
Free Cash Flow 1 4.208 -13.35 -10.01 -23.06 -5.355 -18.55
FCF margin 7.23% -33.25% -104.11% -1,357% -15.86% -36.13%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 11/5/23 11/5/23 11/5/23 11/5/23 11/5/23 4/24/24
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 168 225 249 263 272 282
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -3.368 x -5.321 x -7.851 x -12.62 x -30.41 x 45.09 x
Free Cash Flow 1 4.21 -13.4 -10 -23.1 -5.35 -18.5
ROE (net income / shareholders' equity) 106% 44.2% 18.1% 7.71% 5.75% -3.75%
ROA (Net income/ Total Assets) -13.1% -23.4% -58.3% -56.7% -26.5% 9.35%
Assets 1 504.6 328.6 87.22 46.35 72.49 133.8
Book Value Per Share 2 -0.2300 -0.7400 -0.8900 -0.9700 -1.030 -0.9900
Cash Flow per Share 2 0.0400 0.0100 0 0.0100 0.0100 0.0200
Capex 1 0.52 0.16 - 0.52 0.53 -
Capex / Sales 0.9% 0.41% - 30.84% 1.58% -
Announcement Date 11/5/23 11/5/23 11/5/23 11/5/23 11/5/23 4/24/24
1HKD in Million2HKD
Estimates
  1. Stock Market
  2. Equities
  3. 648 Stock
  4. Financials SoftMedx Healthcare Limited